about
TAVR with mechanically expandable prostheses: Is balloon aortic valvuloplasty really necessary?Transcatheter aortic valve implantation in lower-risk patients: what is the perspective?Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed By Six- Versus Twelve-Month Dual Antiplatelet TAsymptomatic Severe Aortic Stenosis and Noncardiac Surgery.Coronary Access After Transcatheter Aortic Valve Replacement in Patients With Bicuspid Aortic Valve: Lights and Shades.Non-culprit coronary vasospasm in a woman affected by Churg-Strauss syndrome presenting with ST-elevation myocardial infarctionPercutaneous repair of ascending aorta pseudoaneurysm and aortopulmonary fistula with two Amplatzer septal occluder devicesPulmonary artery rupture during right heart catheterization: successful endovascular treatment with Amplatzer Vascular PlugImpella ventricular assist device: A "valvular bypass" to support high-risk percutaneous coronary intervention or complicated transcatheter aortic valve replacementThe interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysisTranscatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis'Full-plastic jacket' with bioresorbable vascular scaffolds: 5-year optical coherence tomography follow-upLeft main bifurcation PCI with the culotte technique using two self-apposing stentsThe impact of pre-existing peripheral artery disease on transcatheter aortic valve implantation outcomes: A systematic review and meta-analysisFactors influencing the choice between transcatheter and surgical treatment of severe aortic stenosis in patients younger than 80 years: Results from the OBSERVANT studyTreatment of aortic stenosis in patients with chronic liver disease: Another win for transfemoral TAVR?Preexisting diastolic dysfunction in patients undergoing TAVR matters-But what about diastole the day after TAVR?
P50
Q47652606-2C41C538-E5E5-45FC-9386-8C7836AD9146Q50094196-0C131124-0C6F-4E72-8C55-02130407CF84Q50938916-C41C779F-63F0-45EE-9859-44965D25E729Q61865582-A4805FFD-AE5E-4745-AA0C-90E1F043D815Q64885743-9C7FA36E-F0B3-42DA-A727-651AFAFFB172Q87554415-38490F48-0274-462A-9396-91E1E4880FA9Q89312629-354D2C2C-7667-49B1-8CB8-6C1BF6851F7FQ89475764-BA02FC98-7929-412A-ADD3-94031AFE29E7Q89750347-C1875795-252E-456D-9BB8-4ADF04DC9673Q90308402-2A9636EA-9DCE-4588-A63D-5ACC9F2C5742Q90423018-67A01086-16E1-4729-B4B9-641EE6CE7DA6Q90609948-9F7488C7-D498-401F-9680-E080A382CE67Q91621854-784D1300-0961-492A-BA4A-3EC5D46D82C6Q92112339-712D9910-B351-4F59-8D2E-E1C39C09CB3EQ92687412-7C2469DE-38E6-43C3-ABDC-0213EB9191E8Q92769276-B27753F6-6C71-498B-91F5-73C1C2880945Q96348372-5B679836-A977-4397-8026-76EB66ABAD13
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Luca Nai Fovino
@en
Luca Nai Fovino
@nl
type
label
Luca Nai Fovino
@en
Luca Nai Fovino
@nl
prefLabel
Luca Nai Fovino
@en
Luca Nai Fovino
@nl
P31
P496
0000-0002-5823-2088